Skip to content
‹ Back to IndustriesSciences

The Future of Fiber Optics Is Looking Bright

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade? The answer: the global fiber optics market. That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion. There is little question that the future is looking bright for fiber optics….

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Promoted Content · · Promoted Content
Share
The Future of Fiber Optics Is Looking Bright

Key takeaways

01

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade?

02

The answer: the global fiber optics market.

03

That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

What kind of industry could potentially have a compound annual growth rate (CAGR) of around 9% over the next decade? The answer: the global fiber optics market. That would mean by 2025, the fiber optic market could be worth approximately $7.52 billion. There is little question that the future is looking bright for fiber optics.

What will drive all of this growth? The primary mainspring is the need for high bandwidth in the maritime environment, the healthcare industry, technological advancements, and upgrades to current systems. Increasing demand for high-speed internet is driving the demand for high-speed fiber optics systems, including higher-capacity optical fibers and system components like optical amplifiers. Everyone wants more bandwidth, and fiber optics is proving it can deliver.

Fiber Optics, VDSL, and Home Demand for High-Speed Internet

Rising internet speeds has led to an increase in demand for Fiber to the Home (FTTH). If anything can slow the growth of fiber optics, though, it’s competition from the latest development in DSL to VDSL. Glass and plastic optical fibers are competing against copper wire, but with the rising prices of copper, it is likely that fiber optics will remain competitive.

Temperature Sensors

One place where fiber optics remains vital is the temperature sensors market. This market is expected to grow by nearly 6% over the next five years, from $5.62 billion in 2018 to $7.48 billion in 2023. Growth is expected from their use in the chemical, consumer electronics (like wearables and smartphones), oil and gas, energy and power, and automotive industries.

Optical Amplifiers

Optical amplifiers are a central component to fiber optics systems, and as the demand for fiber optics increases, so will demand for optical amplifiers. In fact, it’s predicted that the optical amplifier market will grow by around $936 million between 2019 and 2023, averaging a 9% CAGR that keeps step with the projected 9% growth for fiber optical systems. Long- and ultra-long-haul (from cities to continents) networks that amplify signal transmission over long distances will likely be a key growth driver in this sector.

Let Fiberguide Industries Be Your Guide to a Fiber Optical Future

For more than three decades, Fiberguide Industries has been a reliable, long-term strategic partner with OEM manufacturers in providing efficient, cost-effective, practical fiber optic solutions engineered to meet their specific needs. Specializing in manufacturing large core specialty optical fiber and high temperature metalized optical fibers, Fiberguide packages their fibers in a variety of assemblies/bundles to meet the requirements of diverse optical power delivery and optical sensing applications. With corporate headquarters and fiber manufacturing located in Stirling, New Jersey, applications engineering, component, and assembly manufacturing in Caldwell, Idaho, and a sales office and manufacturing in Shanghai, China, Fiberguide Industries is well positioned to serve the needs of their customers globally.

To learn more about how Fiberguide can help guide you to better optical fiber solutions, contact us at https://www.fiberguide.com/ today!

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

PC
Promoted Content
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

PC
Promoted Content

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512